Study of gut microbiota alterations in Alzheimer's dementia patients from KazakhstanOriginal paper
Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease, four years before the first published case study.
Read MoreWhat was studied?
This study examined the diversity and taxonomic composition of gut microbiota in people with Alzheimer's disease (AD) compared to healthy older adults. Researchers used 16S ribosomal RNA sequencing to characterize bacterial communities at the phylum, class, order, and genus levels. The aim was to identify differences in microbial abundance that distinguish AD patients from cognitively healthy seniors living in the same region.
Who was studied?
The study included 41 patients diagnosed with Alzheimer's disease and 43 healthy seniors, all residing in Nur-Sultan city, Kazakhstan. This gives the study a defined, age-matched comparison group of older adults from a single geographic population. No further demographic details such as age range or sex distribution are given in the abstract.
What were the most important findings?
AD patients showed increased relative abundance of the phyla Acidobacteriota, Verrucomicrobiota, Planctomycetota, and Synergistota compared to healthy seniors. At the genus level, AD microbiotas had reduced Bifidobacterium, Clostridia bacterium, Castellaniella, Roseburia, Tuzzerella, Lactobacillaceae, and Monoglobus. Differential abundance analysis also found AD patients enriched for Christensenellaceae R-7 group, Prevotella, Alloprevotella, Ruminococcus, and Akkermansia, among other genera, while Levilactobacillus, Lactiplantibacillus, Bacteroides, and Faecalibacterium were altered in the opposite direction.
What are the greatest implications of this study?
The findings indicate that Alzheimer's disease is associated with a distinct, multi-level shift in gut microbiota composition rather than a single bacterial change. The enrichment of Christensenellaceae R-7 group and Akkermansia alongside depletion of beneficial genera like Bifidobacterium and Roseburia suggests a broader disruption of gut microbial balance in AD. These region-specific findings from Kazakhstan may help identify candidate microbial markers for AD and support future work exploring the gut-brain axis in neurodegeneration.